A Study of Imatinib Versus Nilotinib in Adult Patients With Newly Diagnosed Philadelphia Chromosome Positive (Ph+) Chronic Myelogenous Leukemia in Chronic Phase (CML-CP)
Clinical trial NCT00471497 · COMPLETED
Trial details
- NCT number
- NCT00471497
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-07-31
- Primary completion
- 2009-09-02
- Enrollment
- 846
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.